Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies?

Parkinson's is a heterogeneous, complex condition. Stratification of Parkinson's subtypes will be essential to identify those that will benefit most from a cell replacement therapy. Foetal mesencephalic grafts can alleviate motor symptoms in some Parkinson's patients. However, on‐goin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunath, Tilo, Natalwala, Ammar, Chan, Claire, Chen, Yixi, Stecher, Benjamin, Taylor, Martin, Khan, Sadaquate, Muqit, Miratul M. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Tom Isaacs Special Issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492143/
https://www.ncbi.nlm.nih.gov/pubmed/30586214
http://dx.doi.org/10.1111/ejn.14314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492143/
https://www.ncbi.nlm.nih.gov/pubmed/30586214
http://dx.doi.org/10.1111/ejn.14314

Ejemplares similares